- Home
- ANL vs PDT Comparison
ANL vs PDT Comparison
Compare ANL & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ANL | PDT |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 653.2M |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ANL | PDT |
|---|---|---|
| Price | $11.72 | $12.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 333.5K | 119.7K |
| Earning Date | 04-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $12.53 |
| 52 Week High | $17.25 | $13.65 |
Technical Indicators
Market Signals| Indicator | ANL | PDT |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 44.56 |
| Support Level | $6.92 | $12.82 |
| Resistance Level | $12.09 | $13.45 |
| Average True Range (ATR) | 1.51 | 0.13 |
| MACD | -0.51 | -0.02 |
| Stochastic Oscillator | 20.81 | 33.57 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About PDT John Hancock Premium Dividend Fund
John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest capital growth. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.